Dairy Reporter1mon
Nestlé deepens exploration of bioactives to support muscle health and longevity
Recent studies point to the benefits of a range of bioactives, including nicotinamide, pyridoxine, oleuropein and ...
Seres Therapeutics receives $50 million from Nestlé Health Science
CAMBRIDGE, Mass. - Seres Therapeutics, Inc. (NASDAQ:MCRB), a clinical-stage biotherapeutic company with a market ...
Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment payment related to the Company’s ...
Seres Receives $50 Mln Installment Payment Towards Sale Of VOWST Business To Nestle Health Science
Seres Therapeutics, Inc. (MCRB), a live biotherapeutics company, Thursday said that it has received a $50 million installment payment ...